Literature DB >> 7518371

Expression of non-glial intermediate filament proteins in gliomas.

J Hirato1, Y Nakazato, A Ogawa.   

Abstract

Non-glial intermediate filament (IMF) proteins, as well as glial fibrillary acidic protein (GFAP) and vimentin, were studied by immunohistochemistry in 24 gliomas including low grade astrocytoma, pleomorphic xanthoastrocytoma, anaplastic astrocytoma, glioblastoma, oligodendroglioma, ependymoma and ependymoblastoma, which were fixed in ethanol and embedded in paraffin. Cytoskeletal elements isolated from two glioblastomas were examined with immunoblot analysis. All tumors had GFAP-positive neoplastic cells and vimentin was also found in all the tumors except one oligodendroglioma. Twenty-three gliomas were immunostained with anti-desmin polyclonal antibody (DM-P), but anti-desmin monoclonal antibody reacted to only one glioblastoma. DM-P might crossreact with GFAP and vimentin. Cytokeratin expression was investigated with six antibodies. Twenty gliomas (83%) were positive for the antibody against epidermal keratin (CK-SE), however positive immunoreactivity varied from 58 to 8% with other cytokeratin antibodies. With the Western blot method, CK-SE had protein bands at 53 and 60-66 kDa. Neurofilament was expressed in one pleomorphic xanthoastrocytoma, one anaplastic astrocytoma, one glioblastoma and one ependymoblastoma. Expression of nonglial IMF proteins were observed in 21 tumors (88%), and coexpression of 4 or 5 classes of IMF proteins in 3 tumors (13%). We conclude that, in addition to GFAP and vimentin, gliomas express several types of non-glial IMF proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518371

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  5 in total

1.  Secondary glioblastoma with advanced neuronal immunophenotype.

Authors:  Junji Shibahara; Masashi Fukayama
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

Review 2.  Intermediate filaments in the nervous system: implications in cancer.

Authors:  C L Ho; R K Liem
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

3.  Expression of cytokeratins in glioblastoma multiforme.

Authors:  Tadashi Terada
Journal:  Pathol Oncol Res       Date:  2015-01-30       Impact factor: 3.201

4.  CD15 Expression Does Not Identify a Phenotypically or Genetically Distinct Glioblastoma Population.

Authors:  Emma Kenney-Herbert; Talal Al-Mayhani; Sara G M Piccirillo; Joanna Fowler; Inmaculada Spiteri; Philip Jones; Colin Watts
Journal:  Stem Cells Transl Med       Date:  2015-05-27       Impact factor: 6.940

5.  Prognostic significance of neuronal marker expression in glioblastomas.

Authors:  Kyung-Hwa Lee; Kyung-Joo Kang; Kyung-Sub Moon; Tae-Young Jung; Shin Jung; Jae-Hyoo Kim; Hyung-Seok Kim; Min-Cheol Lee
Journal:  Childs Nerv Syst       Date:  2012-08-26       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.